Furthermore, total IGF1R expression did not differ between surufatinib-response and -non-response CCA tissues, whereas p-IGF1RY1165/1166 was increased in the non-response group (Fig. 3H, Fig. S4D). Here, IGF1R is linked to cholangiocarcinoma.